Bringing New Cancer Drugs to Market with Founder & CEO, Lewis Bender

In this episode, our guest is Lewis Bender, Chairman, and CEO, of Intensity Therapeutics’ Founder which is a late-stage clinical biotechnology company whose mission is to help patients live longer, higher quality lives by discovering, developing, and commercializing first-in-class cancer drugs that attenuate tumors with minimal side effects, while training the patient’s immune system to fight the…